Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Peters

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|December 2, 2014
Burden of changes in generic pill appearanceKathleen Uhl, John R Peters
American Family Physician|September 15, 2018
How the FDA Ensures High-Quality Generic DrugsKathleen Uhl, John R Peters
JAMA Internal Medicine|December 29, 2016
Prioritization of Generic Drug ReviewMaryll Toufanian, John R Peters, Kathleen Uhl
The New England Journal of Medicine|February 12, 2015
High-cost generic drugs--implications for patients and policymakersKathleen Uhl, John R Peters, Keith Flanagan
Current Medical Research and Opinion|January 6, 2006
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)Phil McEwan, John R Peters, Klas Bergenheim, et al.
Diabetes, Obesity & Metabolism|June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debateMarc Evans, Phil McEwan, John R Peters, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Acute psychological stress-induced water intoxicationSagarika Mukherjee, Emmanuel S Antonarakis, S Asaduzzaman, et al.
Diabetes Care|June 29, 2007
Discrepancy between postnatal and antenatal management of gestational diabetes in the U.KFahmy W F Hanna, John R Peters, Joan Harlow, et al.
Current Medical Research and Opinion|December 22, 2005
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK populationCraig J Currie, Phil McEwan, Cathy Emmas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjectsCraig J Currie, Phil McEwan, John R Peters, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|December 2, 2014
Burden of changes in generic pill appearanceKathleen Uhl, John R Peters
American Family Physician|September 15, 2018
How the FDA Ensures High-Quality Generic DrugsKathleen Uhl, John R Peters
JAMA Internal Medicine|December 29, 2016
Prioritization of Generic Drug ReviewMaryll Toufanian, John R Peters, Kathleen Uhl
The New England Journal of Medicine|February 12, 2015
High-cost generic drugs--implications for patients and policymakersKathleen Uhl, John R Peters, Keith Flanagan
Current Medical Research and Opinion|January 6, 2006
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)Phil McEwan, John R Peters, Klas Bergenheim, et al.
Diabetes, Obesity & Metabolism|June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debateMarc Evans, Phil McEwan, John R Peters, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Acute psychological stress-induced water intoxicationSagarika Mukherjee, Emmanuel S Antonarakis, S Asaduzzaman, et al.
Diabetes Care|June 29, 2007
Discrepancy between postnatal and antenatal management of gestational diabetes in the U.KFahmy W F Hanna, John R Peters, Joan Harlow, et al.
Current Medical Research and Opinion|December 22, 2005
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK populationCraig J Currie, Phil McEwan, Cathy Emmas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjectsCraig J Currie, Phil McEwan, John R Peters, et al.
Pageof 3